PRR5 anticorps (AA 51-150) (AbBy Fluor® 750)

N° du produit ABIN5009295

Cet anticorps Lapin Polyclonal détecte spécifiquement PRR5 dans WB, IF (cc) et IF (p). Il présente une réactivité envers Humain.

Aperçu rapide pour PRR5 anticorps (AA 51-150) (AbBy Fluor® 750) (ABIN5009295)

Antigène: PRR5 (Proline Rich 5 (Renal) (PRR5))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp PRR5 est conjugé à/à la AbBy Fluor® 750

Application: Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Détail du produit anti-PRR5 anticorps (AbBy Fluor® 750)

Épitope: AA 51-150

Homologie: Human,Mouse,Rat,Dog,Cow,Pig,Chicken

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human Protor-1

Isotype: IgG

Information d'application

Indications d'application: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur PRR5

Antigène: PRR5 (Proline Rich 5 (Renal) (PRR5))

Autre désignation: Protor-1

Sujet:

Synonyms: Arhgap8, AU043908, C030017C09Rik, C78947, FLJ20185, FLJ20185k, MGC109513, MGC32512, PP610, Proline rich 5 renal, Proline-rich protein 5, Protein observed with Rictor-1, Protor-1, PROTOR1, PRR5, PRR5_HUMAN, PTOR1, RP1-181C9.3.

Background: Protor-1 plays an important role in regulation of PDGF receptor expression and in modulation of PDGF signaling. It is thought that Protor-1 may act as a tumor suppressor in breast cancer.

ID gène: 55615

Pathways: Signalisation PI3K-Akt